Indeed, lycopene exerts significant capacity to inhibit prostate cancer progression demonstrated by reduced levels of inflammatory factors including interleukin (IL)-1, IL-6, Il-8 and tumour necrosis factor-α (TNF-α) in prostate cancer cells in vitro. Here, TNF is linked to prostate carcinoma.